Valuation: MEDADVISO

Market Cap 8.93M 6.28M 5.63M 5.18M 4.69M 8.77M 597M 61.73M 24.78M 314M 23.58M 23.08M 990M P/E 2025
-0.76x
P/E 2026 -1.76x
Enterprise Value -466K -328K -294K -270K -245K -458K -31.13M -3.22M -1.29M -16.38M -1.23M -1.2M -51.65M EV / Sales 2025
0.92x
EV / Sales 2026 -0.05x
Free-Float
68.95%
Yield 2025 *
-
Yield 2026 -
Manager TitleAgeSince
Chief Executive Officer 46 07/11/2025
Chief Tech/Sci/R&D Officer - 30/06/2020
Corporate Secretary - 13/04/2026
Director TitleAgeSince
Director/Board Member - 10/08/2021
Chairman 67 01/04/2025
Director/Board Member 46 07/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+6.52%+8.89% - - 6.28M
-1.72%+3.44%+25.31%+60.56% 258B
-2.00%+0.75%+7.99%+25.46% 163B
-3.73%-4.48%-18.49%+67.13% 150B
-1.66%-8.12%-58.26%-16.12% 60.84B
-2.57%+3.30%+10.22%+47.55% 53.03B
0.00%+2.46%-11.97%-6.29% 53.31B
-3.47%+1.04%+21.98%+72.85% 49.3B
+0.84%-3.12%+9.80%+64.47% 50.67B
-3.61%+1.99%+34.94%+95.49% 45.46B
Average -1.14%-0.30%+2.39%+45.68% 98.16B
Weighted average by Cap. -2.10%+0.15%+5.19%+47.79%

Financials

2025 2026
Net sales 62.99M 44.32M 39.69M 36.51M 33.08M 61.84M 4.21B 435M 175M 2.21B 166M 163M 6.98B 33.96M 23.89M 21.4M 19.68M 17.83M 33.33M 2.27B 235M 94.22M 1.19B 89.66M 87.75M 3.76B
Net income -60.21M -42.36M -37.94M -34.9M -31.62M -59.1M -4.02B -416M -167M -2.12B -159M -156M -6.67B -4.31M -3.03M -2.72M -2.5M -2.26M -4.23M -288M -29.78M -11.96M -151M -11.38M -11.14M -478M
Net Debt 7.09M 4.99M 4.47M 4.11M 3.72M 6.96M 474M 49.02M 19.68M 249M 18.73M 18.33M 786M -9.4M -6.61M -5.92M -5.45M -4.94M -9.23M -628M -64.95M -26.07M -330M -24.81M -24.29M -1.04B
Logo MEDADVISO
Adheris Health Ltd, formerly MedAdvisor Limited, is an Australia-based company engaged in offering pharmacy-driven patient engagement solutions that provide personalized patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, artificial intelligence (AI)-enabled platform, the Company enables the pharmacy with an improved pharmacy workflow and patient engagement solutions. THRiV analyzes hundreds of data points, from prescription history to socioeconomic factors, to anticipate patient needs. This technology allows the Company to deliver personalized strategies tailored to each individual. Its integrated platform provides users to manage, distribute and access medication information, including product information (PIs), consumer medicine information (CMIs) or patient leaflets (PL), instructions for use (IFUs) leaflets or videos, in real time.
Employees
-